Healthy high growth potential

Results

1486

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1486 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
688072
CN¥832.000%413.2%CN¥234.1bCN¥511.08142.435.2%0.04%Semiconductors
CDR
zł237.505.8%-13.3%zł23.7bzł235.1346.029.7%0.4%Media
AGP
€7.304.6%-4.9%€133.1m€8.5726.839.1%n/aCapital Goods
FWRY
ج.م19.445.7%51.2%ج.م66.1bج.م22.4524.927.3%n/aDiversified Financials
MDGL
US$545.361.6%89.7%US$12.2bUS$678.7111.159.2%n/aPharmaceuticals & Biotech
KEBNI B
SEK 1.07-8.0%-56.7%SEK 292.1mSEK 1.252.690.9%n/aTech
LITE
US$698.91-18.5%665.4%US$56.9bUS$1,111.29123.979.1%n/aTech
RHM
€1,111.6012.2%-39.3%€51.8b€1,741.3549.330.6%1.0%Capital Goods
CRDO
US$246.40-9.4%163.9%US$49.5bUS$269.8197.327.5%n/aSemiconductors
MOD
US$230.41-13.7%133.0%US$12.4bUS$340.86100.249.3%n/aCapital Goods
NVDA
US$196.93-0.3%20.9%US$4.7tUS$301.6229.922.2%0.5%Semiconductors
CORT
US$94.048.2%38.0%US$9.8bUS$88.00216.348.9%n/aPharmaceuticals & Biotech
7685
JP¥3,680.0012.0%141.7%JP¥216.7bJP¥4,666.6730.925.5%0.6%Retail
SAUD3
R$14.834.1%32.4%R$43.2bR$16.2176.741.6%5.5%Healthcare
AXSM
US$249.762.0%130.4%US$12.5bUS$276.5618.157.4%n/aPharmaceuticals & Biotech
7769
NT$6,055.00-13.0%345.2%NT$1.1tNT$9,322.7175.643.7%1.1%Semiconductors
1357
HK$4.2914.4%-54.8%HK$18.1bHK$9.3223.131.4%2.3%Media
1729
HK$15.05-11.1%84.9%HK$31.1bHK$25.0042.933.6%0.3%Capital Goods
4417
JP¥3,960.003.9%33.0%JP¥60.1bJP¥4,500.0040.124.1%0.8%Software
AV1
AU$0.0780%-32.2%AU$75.1mAU$0.177.6108.4%n/aSoftware
002810
CN¥22.01-14.2%72.8%CN¥8.4bCN¥36.0038.143.1%1.8%Materials
300432
CN¥17.37-12.0%32.7%CN¥32.7bCN¥34.4058.660.7%0.6%Automobiles
688270
CN¥85.002.5%148.4%CN¥25.9bCN¥185.71169.485.5%0%Semiconductors
MX1
AU$0.034-8.1%-26.1%AU$26.9mAU$0.151.5105.5%n/aHealthcare
Page 1 of 42